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A B S T R A C T
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare type of T-cell lymphoma of CD3+CD8+ phenotype
characterized by deep-seated skin nodules or plaques mimicking panniculitis, a result of neoplastic lymphocytes infil-
trating the subcutaneous fatty tissue. We present a case of a 19-month year old boy with SPTCL diagnosed and success-
fully treated in our institution. Disease first presented with symptoms of high fever and painful erythematous nodule lo-
cated below the umbilicus. Later on the infiltrates appeared on the face, legs, arms and the back of the body. As the most
decisive in obtaining the diagnosis, skin biopsy showed atypical, small to medium-sized lymphatic cells infiltrating the
deeper dermal layers as well as the subcutaneous adipous tissue surrounding the adipocytes. Imunohystochemical anal-
ysis showed neoplastic lymphocytes positive for CD2, CD3, CD5, CD7, CD8, Tia-1, granzyme B and perforine, and nega-
tive for CD20, CD34, TDT and CD56. No infiltration of blood vessels or epidermis was evident. Specific T-cell lympho-
mas protocol (EURO-LB 02) was then initiated which resulted with rapid regression of all general and local symptoms.
The treatment was completed according to schedule and the child is now, 24 months after the initiation of the treatment,
in complete remission.
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Introduction
Subcutaneous panniculitis-like T-cell lymphoma
(SPTCL) is a rare type of cytotoxic T-cell lymphoma
characterized by deep-seated skin nodules or plaques
mimicking panniculitis as a result of neoplastic lympho-
cytes infiltrating subcutaneous fatty tissue. The first de-
scribed in 1991. by Gonzalez et al.1, it is now a distinct
entity according to the World Health Organization classi-
fication regarding its clinical presentation, T-cell recep-
tor phenotype (restricted to only TCRab), immunophe-
notype and prognosis. SPTCL is very rare, making for
less than 1% of all non-Hodgkin lymphomas, and pres-
ents itself most commonly in young adults, twice as often
in females than in males. It is especially rare in child-
hood2. Good clinical prognosis with a 82% 5-year overall
survival ratio is described according to one large mul-
ticentric retrospective study that included 83 patients
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aged 9–793. Still, there are many uncertainties regarding
the optimal therapy and definitive recommendations are
still to be defined.
Case Report
We present a case of a 19-month year old boy with
subcutaneous panniculitis-like T-lymphoma successfully
diagnosed and treated in our clinic. The child was first
admitted to a surgical ward at a local general hospital
with symptoms of high fever and a painful erythematous
nodule located below the umbilicus. The nodule was first
documented 12 days prior to admittance during an exam-
ination of a right-sided inguinal hernia. Seven days be-
fore hospitalization the nodule started growing – turning
into a plaque, a change accompanied by occurrence of
high fever, measuring up to 40 °C. Following admittance,
white blood cell count (WBC) and C-reactive protein
(CRP) tests were ordered along with an ultrasound ex-
amination – while CRP and WBC were not very convinc-
ing (18 mg/L and 5.8109/L, respectively), the ultrasound
showed signs of inflammatory infiltration. A broad-spec-
trum antibiotic treatment was started, but in spite of it,
the plaque became more painful and red, soon measuring
75 cm. An incision was made at the third day of hospi-
talization, but no purulent secretion was noticed.
After two weeks of unsuccessful antibiotic treatment
the child, still in refractory high fever, was transferred to
the clinic for infectious diseases for further treatment
and diagnostic exploration. There, along with the plaque,
then measuring 5´5 cm, marginally enlarged cervical
lymph nodes and a few smaller infiltrations of the facial
skin were noted. A small needle biopsy of an enlarged in-
guinal lymph node was performed showing only reactive
hyperplasia. Fine needle aspiration cytology of facial skin
infiltrates showed few large lymphoid cells with lobular
»cerebriform« nuclei (Figure 1). The next step was to
perform a full-thickness skin biopsy and send the at-
tained specimen further for a full histopathology and
immunohistochemical analysis. For that purpose, three
weeks after starting the workup, the child was admitted
to our clinic for further care. At that time the child was in
high fever for three whole weeks, he was malaise; his
skin was pale and swollen as a result of generalized oe-
dema. Multiple subcutaneous infiltrations were present
all over his abdominal wall, face and scalp with new ones
appearing on his thighs (Figure 2).
The laboratory check-up upon admittance showed ery-
throcyte sedimentation rate 7mm/h and CRP 42 mg/dL
(range, 0–10 mg/dL). There was marked pancytopenia
with WBC 1.8109/L, hemoglobin 8.1g/dL, and platelet
count 67109/L. Liver enzymes were also increased: ala-
nine aminotransferase was 121 U/L (range, 11–38 U/L),
aspartate aminotrasferase 149 U/L (range, 12–48 U/L)
and g-glutamyl transferase 62 U/L (range, 11–55 U/L).
Serum ferritin and lactate dehydrogenase leves were
2535 mg/L (range, 30–400 mg/L) and 1130 U/L (normal
<241 U/L), respectively, and total protein 49 g/L (range,
60–78 g/L).
While waiting for the biopsy results, a multi-slice
computerized tomography scan (MSCT) of the neck, tho-
rax, abdomen and the pelvis was performed, together
with bone marrow aspiration. The MSCT scan showed
only bilateral submandibular lymph node enlargement
(up to 19 mm in diameter) and splenomegaly (12 cm mea-
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Fig. 1. Fine needle aspiration material of skin lesion stained with
May-Grünwald-Giemsa, x1000. Large atypical lymphoid cell with
lobular »cerebriform« nucleus.
Fig. 2. Erythematous infiltrated plaques and subcutaneous
nodules on the face.
Fig. 3. Bone marrow aspirate smear stained with May-Grün-
wald-Giemsa, x1000. Arrows show erythrophagocytosis (erythro-
cytes – left arrow and erytroblast – right arrow) by macrophage.
sured cranio-caudaly). Bone marrow cytomorphology re-
vealed marked erythrophagocytosis (Figure 3). Bone mar-
row immunophenotyping showed no aberrant finding.
Cytogenetic analysis of bone marrow aspirate revealed
normal karyotype (46, XY). Serologic test for hepatitis A,
B and C viruses were negative, specific Epstein-Barr vi-
rus IgG was positive, and IgM was negative.
Twenty-nine days after the first symptoms the results
of the complete workup were attained and a definite di-
agnosis of subcutaneous panniculitis-like T-lymphoma
was established. Histology showed atypical, small to me-
dium-sized lymphatic cells infiltrating the deeper dermal
layers as well as the subcutaneous adipous tissue, sur-
rounding the adipocytes (Figure 4a). In addition, many
histiocytes as well as signs of cariorrhexis and focal ne-
crosis were also noted. Imunohistochemistry showed tu-
mor cells expressing CD2, CD3, CD5, CD7, CD8 (Figure
4b), Tia-1 (Figure 4c), granzyme B and perforine, and
negative results for CD20, CD34, TDT and CD56.
The patient had evidence of haemophagocytic sydro-
me with fever, splenomegaly, pancytopenia, increased se-
rum feritin level and hemophagocytosis on bone marrow
examination (Figure 3). We then initiated a specific
treatment with EURO-LB02 protocol for lymphoblastic
T-lymphomas as follows: cytoreductive pre-phase – pro-
nison; induction protocol – pronison, vincristine, dauno-
rubicine, L-asparaginase in Ia protocol and cyclophosph-
amide, Ara-C and 6-mercaptopurine in IIb protocol, with
intrathecal methotrexate (MTX) according to age. Con-
solidation protocol M: 4xMTX/5.0 g/m2; re-induction pro-
tocol – dexamethason, vincristine, doxorubicine, L-aspa-
raginase in IIa and 6-thioguanine, cyclophosphamide,
Ara-C in IIb, and intarthecal MTX according to age.
Maintenance therapy included purinethol followed by
methotrexate. The chemotherapy was followed by rapid
regression of all general and local symptoms.
After 3 days of treatment the child was no longer fe-
brile and the skin lesions became more and more pale
eventually completely regressing in two week’s time. A
control skin biopsy was performed three months after
the initiation of treatment showing no elements charac-
teristic for SPTCL, with only localized pseudomembra-
nous degeneration of fatty cells – a likely effect of chemo-
therapy. The course of the treatment was not marred by
any major complications, no unexpected side-effects were
noted. Only one major infection, Candida sepsis four
months after initiation of chemotherapy had to be trea-
ted with systemic antifungal drugs outside the standard
protocol. The planned treatment was nonetheless contin-
ued and completed according to schedule.
Twenty-four months after starting the treatment the
boy is in remission and we discontinued the maintenance
therapy (purinethol+methotrexate). Full 24 months af-
ter the diagnosis was established the protocol was com-
pleted and saw the child in full remission. Outpatient fol-
low-up is in progress.
Discussion and Conclusion
Subcutananeous panniculitis-like T-cell lymphoma
(SPTCL) is a distinctive skin lymphoma that is charac-
terized by infiltration of subcutaneous tissue by neoplas-
tic T-cells of cytotoxic phenotype mimicking panniculitis.
Gonzales et al.1 first described T-cell lymphoma involving
the subcutaneous tissue in 1991. Willemze et al.3 ana-
lyzed the larger group of 83 cases. Their study show clear
cut differences not only between SPTL with an ab T-cell
phenotype (SPLT-ab) and SPLT with a gd T-cell pheno-
type (SPLT-gd), but also between SPLT-ab with and those
without haemophagocytic syndrome (HPS). In contrast,
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Fig. 4. a. Infiltrate of small lymphocytes rimming the fat cells in
the subcutaneous tissue (HE, x400), b. The neoplastic cells show
cytoplasmatic immunostaining for CD8 (x400), c. Granular TIA-1
cytoplasmatic positivity of tumor cells (x400).
a)
b)
c)
in the group of SPTL-gd no difference in survival was
found between patients with and patients without HPS.
Resulting from its rarity in childhood, there are no
specific, widely accepted recommendations for treatment
of subcutaneous panniculitis-like T-lymphoma inside that
specific population group4,5. Recently, Koh et al.6 pre-
sented the results of 16 cases of children treated from
SPTCL clearly showing the variations in treatment mo-
dalities that ranged from monotherapy (prednisone or
prednisone and cyclosporine) to multidrug chemother-
apy followed by autologous peripheral blood stem cell
transplantation.
In this report we present evidence for a good outcome
after treatment with EURO-LB 02 protocol, a standard
in the therapy of other T-cell lymphomas of mature phe-
notype. Although our case does not present a definite
guideline, it is indicative of the direction further treat-
ment efforts should focus to. It is still uncertain whether
the protocol should be supplemented with a prophylactic
CNS irradiation treatment. Respecting the child’s age at
the time of diagnosis and taking into account that no
clear benefit in survival rate resulting from radiation is
established so far, we decided not to go through with it.
Based on sporadic cases of children with SPTCL pre-
sented to date, we clearly argue that a definite treatment
should be established and that the T-lymphoma therapy
protocol, with or without additional radiation, could just
be the one.
R E F E R E N C E S
1. GONZALEZ CI, MEDEIROS LJ, BRAZIIEL RM, JAFFE ES, Am J
Surg Pathol, 15 (1991) 17. — 2. WILLEMZE R, JAFFE ES, BURG G,
CERRONI L, BERTI E, SWERDLOW SH, RALFKIAER E, CHIMENTI
S, DIAZ-PEREZ JL, DUNCAN LM, GRANGE F, HARRIS NL, KEMPF W,
KERL H, KURRER M, KNOBLER R, PIMPINELLI N, SANDER C, SAN-
TUCCI M, STERRY W, VERMEER MH, WECHSLER J, WHITTAKER S,
MEIJER CJ, Blood, 105 (2005) 3768. — 3. WILLEMZE R, JANSEN PM,
CERRONI L, BERTI E, SANTUCCI M, ASSAF C, CANNINGA-VAN
DIJK MR, CARLOTTI A, GEERTS ML, HAHTOLA S, HUMMEL M,
JESKANEN L, KEMPF W, MASSONE C, ORTIZ-ROMERO PL, PAULLI
M, PETRELLA T, RANKI A, PERALTO JL, ROBSON A, SENFF NJ,
VERMEER MH, WECHSLER J, WHITTAKER S, MEIJER CJ, Blood, 111
(2008) 838. — 4. SHANI-ADIR A, LUCKY AW, PRENDIVILLE J, MUR-
PHY S, PASSO M, HUANG FS, PALLER AS, J Am Acad Dermatol, 50
(2004) 518. — 5. GO RS, WESTER SM, Cancer, 101 (2004) 1404. — 6.
KOH MJ, SADARANGANI SP, CHAN YC, CHAN MY, TAN AM, TAN SH,
TAY YK, NG SB, J Am Acad Dermatol, 61 (2009) 875.
Lj. Raji}
Department of Haematology and Oncology, Pediatric Clinic, Zagreb University Hospital Center and Zagreb University
School of Medicine, Ki{pati}eva 12, 10000 Zagreb, Croatia
e-mail: ljubica.rajic@yahoo.com
POTKO@NI T-STANI^NI LIMFOM NALIK PANIKULITISU U 19-MJESE^NOG DJE^AKA:
PRIKAZ SLU^AJA
S A @ E T A K
Potko`ni T-stani~ni limfom nalik panikulitisu (engl. subcutaneous panniculitis-like T-cell lymphoma, SPTCL) jest
rijetki oblik T-stani~nog limfoma fenotipa CD3+CD8+ kojeg karakteriziraju duboki ko`ni ~vori}i ili plakovi nalik pan-
niculitisu, a koji nastaju kao rezultat infiltracije potko`nog masnog tkiva neoplasti~nim limfocitima. U ovom radu pri-
kazujemo slu~aj 19-mjese~nog dje~aka sa SPTCL koji je dijagnosticiran i uspje{no lije~en u na{oj ustanovi. Bolest se
isprva prezentirala visokom vru~icom i bolnim eritematoznim ~vori}ima ispod pupka. Kasnije su se infiltrati pojavili na
licu, nogama, rukama i le|ima. U postavljanju dijagnoze najodlu~niji je bio patohistolo{ki nalaz biopsije ko`e koji je
pokazao infiltraciju atipi~nih, malenih do srednje velikih limfati~nih stanica u dubljim slojevima dermisa i potko`nom
tkivu oko adipocita. Na imunohistokemijskoj analizi neoplasti~ni limfociti su izra`avali biljege CD2, CD3, CD5, CD7,
CD8, Tia-1, granzim-B i perforin, a bili su negativni na CD20, CD34, TDT i CD56. Nije na|ena infiltracija krvnih `ila i
epidermisa. U djeteta je zapo~eto lije~enje protokolom specifi~nim za T-stani~ne limfome (EURO-LB 02) {to je uskoro
dovelo do brzog povla~enja svih op}ih i lokalnih simptoma. Lije~enje je zavr{eno prema planu, a dijete je danas, 24
mjeseca od po~etka terapije u kompletnoj remisiji bolesti.
Lj. Raji} et al.: Subcutaneous Panniculitis-like T-cell Lymphoma, Coll. Antropol. 34 (2010) 2: 679–682
682
